Gamal Esmat

Gamal Esmat is a professor at Endemic Medicine and Hepatogastroenterology Department, Cairo University.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Gamal Esmat is a professor at Endemic Medicine and Hepatogastroenterology Department, Cairo University. He was vice president of Cairo University for Graduate Studies and Research. Esmat has published scientific papers in journals on hepatitis, hepatocellular carcinoma and liver transplantation.

Since 2001, he is the director of Clinical Research Unit, Hepatitis C Project, International Health Division, University of Maryland, Baltimore. Esmat was the president of IASL (International Association for the Study of the Liver) during the period 2006 – 2008 and is recently the WHO consultant for management of viral hepatitis.

Research and achievements

Esmat has worked in epidemiology, treatment and prevention of viral hepatitis, also enabling individualization of its treatment. He later developed further treatment strategies using the first Egyptian developed HCV Direct Antiviral Agent (DAA) for the hard-to-treat, interferon experienced and cirrhotic patients, revolutionizing HCV treatment.

http://www.gamalesmat.com/about_us.aspx

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365595909 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

4 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.